// App-Quantinova.ai

CTIM-25 : ONCOLYTIC VIRUS FOR DIPG: THE CLINICAL EXPERIENCE WITH DNX-2401

Researchers

Presenter

  • Marta M Alonso

Principal Investigators

  • Marc Garcia-Moure

  • Marisol Gonzlez-Huarriz

  • Chris Jones

  • Alan MACKAY

  • Esther Hulleman

  • Jasper Van der Lugt

  • Carlos De Andrea

  • Maria Villalba

  • Ruben Hernandez

  • Sandra Hervs

  • Ibon Tamayo

  • Frederick Lang

  • Candelaria Gomez-Manzano

  • Juan Fueyo

  • Ricardo Diez-Valle

  • Jaime Gllego-prez de Larraya

  • Sonia Tejada

Medical Centers

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

  • Princess Maxima, Rotterdam, Netherlands

  • CUN, Pamplona, Spain

  • Quiron, Madrid, Spain

Locations

  • Spain

  • United Kingdom

  • Netherlands

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Diffuse intrinsic pontine glioma

  • Acquired immunodeficiency syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Delta-24-RGD-4C

  • Propel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT03178032

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved